6月29日，赛诺菲与领导团队的主要成员在疫苗投资者活动中专门讨论了其研发的产品管线，旨在通过创新推动疫苗可持续发展。详细阅读
One thought on “赛诺菲疫苗瞄准RSV、痤疮、PCV21、流感、脑膜炎，并解锁下一代mRNA技术”
Leave a Reply
You must be logged in to post a comment.
MEDTALE (Beijing) Investment Management Co., Ltd.
MEDTALE (Beijing) Investment Management Co., Ltd.
Hi, this is a comment.
To get started with moderating, editing, and deleting comments, please visit the Comments screen in the dashboard.
Commenter avatars come from Gravatar.